Accreditation/Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 6.75 Contact Hours.
Acknowledgment of Commercial Support
This activity is supported by educational grants from Genentech, Inc., Incyte Corporation, and Novartis Pharmaceuticals Corporation.
12th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
Click here to download brochure
Eden Roc Miami
4525 Collins Avenue
Miami Beach, FL 33140
The 12th Annual International Symposium on Melanoma and Other Cutaneous Malignancies® is a 1-day educational and scientific meeting that will focus on key clinical topics in the management of melanoma and other cutaneous malignancies.
The field of skin cancer treatment remains one of the most rapidly evolving areas in oncology and has been a major focus of novel drug development. In particular, the advent of targeted and immunotherapeutic approaches to manage these malignancies has transformed care in recent years. There are also many investigational strategies in late-stage development, and these promise to further change practice in 2016. This is great news for patients, but also challenges busy clinicians to maintain state-of-the-art approaches in their practices.
This year’s program will focus on a number of core areas that are key to personalizing care for these tumors in contemporary practices settings, including sessions on immunotherapies, targeted therapies, regional therapy, and integrated medicine/patient care. This fast-paced, highly practical, and interactive forum will once again provide physicians who treat patients with skin cancer unique access to renowned international experts in the management of these tumors.
This educational activity is directed toward medical oncologists, fellows, surgical oncologists, and radiation oncologists who treat patients with skin and other cutaneous malignancies. Dermatologists, dermatopathologists and pathologists, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of melanoma and other cutaneous malignancies will be invited to participate.
At the conclusion of this activity, participants should be better prepared to:
- Choose treatment based on patient characteristics, such as age and performance status
- Assess the roles of regional therapies, targeted therapies, and immunotherapies in the treatment of patients
- Review strategies for mitigating and managing adverse events related to therapy
- Describe current and emerging strategies for individualizing therapy
- Evaluate emerging clinical data regarding new regional therapies, targeted therapies, and immunotherapies in treating melanoma and other cutaneous malignancies
Jeffrey Weber, MD, PhD
Laura and Isaac Perlmutter Cancer Center
Professor of Medicine
NYU Langone Medical Center
New York, NY
Omid Hamid, MD
Chief, Translational Research & Immuno-Oncology
Director, Cutaneous Malignancies – The Angeles Clinic and Research Institute
Director of Experimental Therapeutics, Cedars Sinai Medical Care Foundation
Los Angeles, CA
Keynote SpeakerBob Griese
Chair, Moffitt Board of Advisors
Miami Dolphins Radio Analyst
Member, College and Pro Football Halls of Fame
You must be logged in to PER to register for this meeting
Or Register for PER now
In case of onsite emergency:
Assumption of Risk and Waiver of Liability Relating to Coronavirus/COVID-19
I understand that the hazards of the novel coronavirus ("COVID-19") and have reviewed the Centers for Disease Control and Prevention ("CDC") current guidelines in regards to COVID-19. I acknowledge that while Physicians' Education Resource, LLC ("PER") ("Company") has put in place preventative measures to reduce the spread of COVID-19, Company cannot guarantee that I or anyone else will not become infected with COVID-19. I attest that if within the fourteen (14) days prior to the event, I am experiencing any symptoms of COVID-19, or I have been in close contact with anyone that has been diagnosed with COVID-19, then I will not attend the Activities. I shall follow any safety, social distancing, masking, and hygiene protocols that have been implemented at the Activities.
I hereby willingly and voluntarily choose to attend this PER event and related activities ("Activity"). I acknowledge and fully assume the risk and hazards of exposure to COVID-19 and that such exposure or infection may result in personal injury, illness, permanent disability, and death to myself, my spouse, children, unborn child, or relatives. I hereby release covenant not to sue, forever discharge, and hold harmless Company and its affiliates from all liability claims and demands of whatever kind of nature, either in law or in equity, which arise or may hereafter arise from participating in the Activities. I assume all risks of losses, damages, or injuries that may be sustained while participating in the Activity. I understand and agree that this release includes any Claims based on the actions, omissions, or negligence of the venue, employees, vendors, agents, and representatives, whether a COVID-19 infection occurs before, during, or after participation in the Activity.
* By checking this box, you have read and understand the above and agree to its terms.